After Cantor Fitzgerald and SunTrust Robinson gave LHC Group (NASDAQ: LHCG) a Buy rating last month, the company received another Buy, this time from Oppenheimer. Analyst Michael Wiederhorn maintained a Buy rating on LHC Group today and set a price target of $110. The company’s shares closed on Friday at $97.70, close to its 52-week high of $103.79.
Wiederhorn wrote:
“We attended meetings with LHC Group’s management, including CEO Keith Myers, CFO Joshua Proffitt, SVP of and EVP and an impressive recent addition to the C-Suite who adds a new dimension the company has never had. Following the meetings, we believe the company is well-positioned given the successful ongoing integration of the significant margin opportunity beyond even the conservative synergies assumed in guidance. With respect to reimbursement, the company is hopeful that the 6% behavioral adjustment will not be implemented, whether it is removed through the regulatory process or by Congress. Overall, we believe LHCG is in prime position to outperform OPCO/Street expectations over the coming years.”
According to TipRanks.com, Wiederhorn is a top 100 analyst with an average return of 17.8% and a 72.4% success rate. Wiederhorn covers the Services sector, focusing on stocks such as Cross Country Healthcare, Addus Homecare Corp, and Community Health.
LHC Group has an analyst consensus of Strong Buy, with a price target consensus of $110.33.
See today’s analyst top recommended stocks >>
LHC Group’s market cap is currently $2.99B and has a P/E ratio of 39.72. The company has a Price to Book ratio of 2.37.
Based on the recent corporate insider activity of 40 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
LHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Community-Based Services and Facility-Based Services.
